Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02401815
Title PLX9486 as a Single Agent and in Combination With PLX3397 or PLX9486 With Sunitinib in Patients With Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Plexxikon

gastrointestinal stromal tumor

Advanced Solid Tumor


PLX9486 + Sunitinib

Pexidartinib + PLX9486


Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST